Our Products
Our Products

Events Gallery

Ground-breaking Ceremony – September 2018

AGP Limited has started the construction of its new office building and ground-breaking ceremony was held on Sep 5, 2018. The Chief Executive Officer inaugurated the commencement of the excavation and the ceremony was attended by senior management of the Company. The building complex is expected to be completed by the end of calendar year 2019.

Analyst Briefing – August 2018

An Analyst Briefing was held to discuss the financial results of the Company for the half year ended June 30, 2018 at Pearl Continental Hotel on Thursday August 09, 2018.

Analyst Briefing Presentation Jan – June 2018 Performance

Cardio-Metabolic Team – July 2018

Going further on the path of our success, we have developed a Cardio-Metabolic team that promotes products for the treatment of diabetes, heart disease or stroke. This team will be mainly associated with our brands namely Rivarox (Rivaroxaban) an oral anti-coagulant and antidiabetic products such as Gluconorm (Glimepiride), Poze (Pioglitazone) and their combinations.

Road Safety Campaign – May 2018

AGP Limited conducted a Road Safety Campaign in collaboration with Sindh Traffic Police near National stadium Karachi at Qasim Umar Road Flyover. The campaign was aimed at improving road safety by engaging general public to change unsafe behavior on the road. The safety awareness messages were displayed on panaflex around one of the main pillar of the flyover along with AGP Team holding placards with road safety information. The AGP team also distributed road safety awareness brochures to the general public.

Cinklare Launch – April 2018

The Company has launched Cinklare (cefixime) in three strengths; 400 mg capsules, 100 mg and 200 mg suspension. The drug is indicated for the treatment of infections including typhoid, diarrhea, pneumonia, middle ear infections & urinary tract infections.

Gong-ringing Ceremony – March 2018

Gong-ringing ceremony of AGP was held at the PSX on Monday, March 5, 2018. Immediately after the start of trading, the shares of AGP hit the upper circuit of 5 percent to take the stock price to Rs 84, from the offered price of Rs 80 a share. AGP is the first public offering of a Pharmaceutical company after a gap of over 23 years. AGP offered 35 million shares (12.5% of the capital) to foreign and local high net-worth institutional and individual investors through book building and initial public offering both of which received overwhelming response.

Neogene Launch Jan-2018

AGP launches yet another broad spectrum antibiotic, Neogene in Jan 2018. It is used in injectable form for the treatment of number of bacterial infections. It is also used before and after the surgical procedures to prevent infections. Consistent with our slogan “We Value Life” and going further with our safety theme, not only the medicine is environment friendly, AGP has also used best quality ampule which contains quantities of arsenic (toxic material) even less than allowable and the ampoule becomes more safe and healthy to use.